CORCEPT THERAPEUTICS INC Purchase Obligation
CORCEPT THERAPEUTICS INC (CORT) had Purchase Obligation of $10.20 million as of 2026-03-31, per its 10-Q filed 2026-07-29.
Financial Statements › Notes › Commitment and Contingencies
us-gaap:PurchaseObligation · last filed 2026-07-29
- 2026-03-31: Purchase Obligation $10.20M.
- 2025-12-31: Purchase Obligation $10.70M.
- 2024-12-31: Purchase Obligation $17.40M.
- 2023-12-31: Purchase Obligation $700.00K.
| Period end | Purchase Obligation |
|---|---|
| 2026-03-31 | $10.20M 10-Q · filed 2026-07-29 |
| 2025-12-31 | $10.70M 10-K · filed 2026-02-24 |
| 2024-12-31 | $17.40M 10-K · filed 2025-02-26 |
| 2023-12-31 | $700.00K 10-K · filed 2024-02-15 |
| 2012-09-30 | $3.20M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $2.80M 10-Q · filed 2012-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |